Park, Hyo Jung
Kim, Hyoung Jung
Kim, Kyung Won
Kim, So Yeon
Choi, Sang Hyun
You, Myung-Won
Hwang, Hee Sang
Hong, Seung-Mo
Article History
Received: 15 January 2020
Revised: 13 March 2020
Accepted: 6 April 2020
First Online: 28 April 2020
Compliance with ethical standards
:
: The scientific guarantor of this publication is Hyoung Jung Kim.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in:a. Kim DW, Kim HJ, Kim KW, et al (2015) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 25:1375–1383.b. Kim JY, Kim MS, Kim KS, et al (2015) Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumours. Am J Surg Pathol 39:592–601.c. Son EM, Kim JY, An S et al (2015) Clinical and prognostic significances of cytokeratin 19 and KIT expression in surgically resectable pancreatic neuroendocrine tumors. J Pathol Transl Med 49:30–36.d. Hwang HS, Kim Y, An S et al (2018) Grading by the Ki-67 labeling index of endoscopic ultrasound-guided fine-needle aspiration biopsy specimens of pancreatic neuroendocrine tumors can be underestimated. Pancreas 47:1296–1303.
: • retrospective• diagnostic or prognostic study• performed at one institution